In the study by Sato et al., patients with pSS had increased levels of anti-SSA/Ro antibodies and mildly positive antinuclear antibodies (ANA) 1:40 at the time of PAH diagnosis. Here, BTG3 is linked to pulmonary arterial hypertension.